ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 86 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 1.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,830 | -15.7% | 351,064 | 0.0% | 0.08% | -4.5% |
| Q2 2023 | $324,734 | -15.1% | 351,064 | 0.0% | 0.09% | -22.6% |
| Q1 2023 | $382,660 | -25.3% | 351,064 | 0.0% | 0.12% | -20.1% |
| Q4 2022 | $512,553 | +36.0% | 351,064 | 0.0% | 0.14% | +42.6% |
| Q3 2022 | $377,000 | -36.9% | 351,064 | 0.0% | 0.10% | -38.0% |
| Q2 2022 | $597,000 | -17.4% | 351,064 | 0.0% | 0.16% | -13.3% |
| Q1 2022 | $723,000 | +41.5% | 351,064 | +157.6% | 0.19% | +46.9% |
| Q4 2021 | $511,000 | +151.7% | 136,266 | +446.0% | 0.13% | -20.5% |
| Q2 2016 | $203,000 | -71.6% | 24,955 | -71.7% | 0.16% | -73.9% |
| Q1 2016 | $716,000 | +23.4% | 88,100 | +83.2% | 0.62% | +19.5% |
| Q4 2015 | $580,000 | – | 48,100 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 38,974,185 | $166,030,000 | 1.81% |
| Endurant Capital Management LP | 1,539,435 | $6,558,000 | 1.80% |
| NEA Management Company, LLC | 17,082,611 | $72,772,000 | 0.95% |
| PFM Health Sciences, LP | 3,627,900 | $15,455,000 | 0.48% |
| GSA CAPITAL PARTNERS LLP | 513,388 | $2,187,000 | 0.25% |
| Baker Brothers Advisors | 9,830,877 | $41,880,000 | 0.18% |
| Avoro Capital Advisors LLC | 2,024,400 | $8,624,000 | 0.15% |
| Vigilare Wealth Management | 54,250 | $231,000 | 0.14% |
| AlphaCentric Advisors LLC | 120,000 | $511,000 | 0.14% |
| Rock Springs Capital Management LP | 1,545,000 | $6,582,000 | 0.13% |